Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework

Published:2024-03-15 Issue:6 Volume:18 Page:265-277
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Wang Eric¹^ORCID,Henderson Mackenzie¹^ORCID,Yalamanchili Priyanka¹²^ORCID,Cueto Jenilee¹^ORCID,Islam Zahidul¹^ORCID,Dharmani Charles¹^ORCID,Salas Maribel¹³^ORCID

Affiliation:

1. Daiichi-Sankyo, Inc., Basking Ridge, NJ 07920, USA

2. Rutgers Institute for Pharmaceutical Industry Fellowships, Piscataway, NJ 08854, USA

3. Center for Real-world Effectiveness & Safety of Therapeutics (CREST), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA

Funder

Daiichi Sankyo Company

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/bmm-2023-0048

Reference66 articles.

1. SEER Cancer Statistics Factsheets. Female Breast Cancer. National Cancer Institute, Bethesda, MD, USA (2022).

2. Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002−2006 and 2007−2011

3. Biomarkers. National Institute of Environmental Health Sciences. Research Triangle Park, NC, USA (2022).

4. About Biomarkers and Qualification. US FDA Silver Spring MD USA (2022).

5. Biomarker definitions and their applications

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer;Laboratory Investigation;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP